These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 5862330)
1. [Prophylaxis of cancer seen by a clinician]. Bauer KH Riforma Med; 1965 Oct; 79(43):1181-4. PubMed ID: 5862330 [No Abstract] [Full Text] [Related]
2. [The state of cancer prophylaxis in Germany]. RUMMEL A Krebsarzt; 1957 Apr; 12(2):95-7. PubMed ID: 13439967 [No Abstract] [Full Text] [Related]
3. [Public enlightenment on cancer as a means of prophylaxis]. ERDMANN CF Krebsarzt; 1960 Jun; 15():240-3. PubMed ID: 13697074 [No Abstract] [Full Text] [Related]
4. [From genetic screening to surgical cancer prophylaxis]. Rothmund M Dtsch Med Wochenschr; 2000 Jan; 125(3):35-6. PubMed ID: 10681996 [No Abstract] [Full Text] [Related]
5. [Predominant approach to pathogenesis, prophylaxis and therapy of cancer]. Bukhtoiarov OV; Arkhangel'skiĭ AE Vopr Onkol; 2007; 53(3):253-61. PubMed ID: 18198603 [No Abstract] [Full Text] [Related]
6. The cancer registry as a tool to detect industrial risks. Jensen OM Bull Cancer; 1983; 70(5):423-8. PubMed ID: 6667354 [TBL] [Abstract][Full Text] [Related]
7. Assessing cancer-related quality of life across a spectrum of applications. Gotay CC J Natl Cancer Inst Monogr; 2004; (33):126-33. PubMed ID: 15504923 [TBL] [Abstract][Full Text] [Related]
8. Cancer screening in theory and in practice. Brawley OW; Kramer BS J Clin Oncol; 2005 Jan; 23(2):293-300. PubMed ID: 15637392 [TBL] [Abstract][Full Text] [Related]
9. [Tasks of prophylaxis in oncology]. DYMARSKII LIu Feldsher Akush; 1954 Aug; 8():31-5. PubMed ID: 13200574 [No Abstract] [Full Text] [Related]
10. [Result of an action of systematic anticancerous prophylaxis carried out on the population of an arrondissement]. RAMIOUL H; LIEGEOIS A Bull Assoc Fr Etud Cancer; 1961; 48():75-97. PubMed ID: 13739334 [No Abstract] [Full Text] [Related]
11. [Cancer and thrombosis]. Madoiwa S Gan To Kagaku Ryoho; 2009 Nov; 36(11):1781-7. PubMed ID: 19920377 [TBL] [Abstract][Full Text] [Related]
12. Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL). Kalka C; Spirk D; Siebenrock KA; Metzger U; Tuor P; Sterzing D; Oehy K; Wondberg D; Mouhsine el Y; Gautier E; Kucher N Thromb Haemost; 2009 Jul; 102(1):56-61. PubMed ID: 19572068 [TBL] [Abstract][Full Text] [Related]
13. Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization? Weycker D; Hackett J; Edelsberg JS; Oster G; Glass AG Ann Pharmacother; 2006 Mar; 40(3):402-7. PubMed ID: 16492793 [TBL] [Abstract][Full Text] [Related]
14. Ethical considerations in relation to aspirin prophylaxis. Morgan G Qual Prim Care; 2008; 16(6):433-40. PubMed ID: 19094419 [TBL] [Abstract][Full Text] [Related]
15. Patient and provider priorities for cancer prevention and control: a qualitative study in Mid-Atlantic Latinos. O'Malley AS; Rentería-Weitzman R; Huerta EE; Mandelblatt J; Ethn Dis; 2002; 12(3):383-91. PubMed ID: 12148710 [TBL] [Abstract][Full Text] [Related]
16. Screening for cancer and pre-cancer. Mera SL Br J Biomed Sci; 1995 Jun; 52(2):120-41. PubMed ID: 8520249 [TBL] [Abstract][Full Text] [Related]
17. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice. Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E; Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976 [TBL] [Abstract][Full Text] [Related]
18. Molecular genetics and management strategies in hereditary cancer syndromes. Hanna NN; Mentzer RM J Ky Med Assoc; 2003 Mar; 101(3):100-7. PubMed ID: 12674901 [TBL] [Abstract][Full Text] [Related]
19. Programmed instruction: cancer care. Cancer prevention: cancer risk factors. Avellanet C Cancer Nurs; 1982 Aug; 5(4):295-313. PubMed ID: 6921077 [No Abstract] [Full Text] [Related]
20. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Kismet K; Akay MT; Abbasoglu O; Ercan A Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]